P. Zuluaga

发表

Endobronchial mass as the first manifestation of an anaplastic T-cell lymphoma☆

J. Navarro, S. Martí, P. Zuluaga, 2015 .

Over-expression of CD8+ T-cell activation is associated with decreased CD4+ cells in patients seeking treatment of Alcohol Use Disorder.

A. Teniente, E. Martínez-Cáceres, J. Tor, 2017, Drug and alcohol dependence.

Is moderate alcohol consumption healthy? The evolution of evidence

P. Zuluaga, J. Colom, 2019, Medicina Clínica (English Edition).

Safety of nalmefene for the treatment of alcohol use disorder: an update

W. van den Brink, K. Mann, A. Gual, 2019, Expert opinion on drug safety.

Hepatitis C associated with substance abuse: ever closer to a treatment without Interferon Hepatitis C asociada al abuso de sustancias: nunca tan cerca de un tratamiento sin Interferón

J. Tor, D. Fuster, R. Muga, 2015 .

Hepatitis C associated to substance abuse: ever closer to a treatment without Interferon.

J. Tor, D. Fuster, R. Muga, 2015, Adicciones.

Long-Term Outcomes of Patients With Cocaine Use Disorder: A 18-years Addiction Cohort Study

M. Farré, E. Papaseit, D. Fuster, 2021, Frontiers in Pharmacology.

Increased Natural Killer Cells Are Associated with Alcohol Liver Fibrosis and with T Cell and Cytotoxic Subpopulations Change

E. Martínez-Cáceres, D. Fuster, R. Muga, 2022, Journal of clinical medicine.

Long-Term Mortality of Patients with an Alcohol-Related Wernicke–Korsakoff Syndrome

J. Tor, D. Fuster, A. Chamorro, 2017, Alcohol and alcoholism.

Wide array of T-cell subpopulation alterations in patients with alcohol use disorders.

A. Teniente, E. Martínez-Cáceres, J. Tor, 2016, Drug and alcohol dependence.

Markers of Inflammation and Mortality in a Cohort of Patients With Alcohol Dependence

J. Tor, D. Fuster, R. Muga, 2015, Medicine.

Assessment of liver disease in patients with chronic hepatitis C and unhealthy alcohol use

D. Fuster, R. Muga, F. Bolao, 2021, World journal of gastroenterology.

Folate deficiency in patients seeking treatment of alcohol use disorder.

J. Juncà, J. Tor, D. Fuster, 2017, Drug and alcohol dependence.

Sex-specific disease outcomes of HIV-positive and HIV-negative drug users admitted to an opioid substitution therapy program in Spain: a cohort study

M. Torrens, J. Tor, D. Fuster, 2014, BMC Infectious Diseases.

DSM-5 in patients seeking their first treatment for alcohol use disorder. Sex differences in the multicenter CohRTA study.

G. Rubio, M. Torrens, F. Rodríguez de Fonseca, 2019, Adicciones.

Meconium Biomarkers of Prenatal Alcohol Exposure

M. Farré, E. Papaseit, R. Muga, 2019, Neuroscience of Alcohol.

Alcohol Consumption during Pregnancy: Analysis of Two Direct Metabolites of Ethanol in Meconium

M. Farré, J. Tor, R. Muga, 2016, International journal of molecular sciences.

Patients with alcohol use disorder: initial results from a prospective multicenter registry in the Spanish Network on Addiction Disorders. CohRTA Study.

M. Farré, G. Rubio, M. Torrens, 2018, Adicciones.

Markers of Monocyte Activation, Inflammation, and Microbial Translocation Are Associated with Liver Fibrosis in Alcohol Use Disorder

D. Fuster, R. Muga, F. Bolao, 2021, Journal of clinical medicine.

Significance of Markers of Monocyte Activation (CD163 and sCD14) and Inflammation (IL-6) in Patients Admitted for Alcohol Use Disorder Treatment.

J. Tor, D. Fuster, R. Muga, 2019, Alcoholism, clinical and experimental research.

Liver Ultrasound Abnormalities in Alcohol Use Disorder

J. Tor, D. Fuster, R. Muga, 2019, Essentials of Abdominal Ultrasound.

Ultrasound findings of liver damage in a series of patients consecutively admitted for treatment of alcohol use disorder.

J. Tor, D. Fuster, R. Muga, 2018, Drug and alcohol dependence.

Impact of the 2009 influenza A H1N1 pandemic on invasive pneumococcal disease in adults

J. Rello, J. Burgos, I. Casas, 2014, Scandinavian journal of infectious diseases.

Pneumocystis jirovecii pneumonia in HIV-1-infected patients in the late-HAART era in developed countries

B. Clotet, A. Ornelas, J. Tor, 2013, Scandinavian journal of infectious diseases.

Cannabis as Secondary Drug Is Not Associated With a Greater Risk of Death in Patients With Opiate, Cocaine, or Alcohol Dependence.

M. Farré, J. Tor, D. Fuster, 2017, Journal of addiction medicine.

Cannabis use is associated with monocyte activation (sCD163) in patients admitted for alcohol use disorder treatment.

J. Tor, D. Fuster, R. Muga, 2020, Drug and alcohol dependence.

Do serum markers of liver fibrosis vary by HCV infection in patients with alcohol use disorder?

A. Muñoz, M. Farré, J. Tor, 2018, Drug and alcohol dependence.

Fungal plasma biomarkers in patients admitted for hospital treatment of alcohol use disorder.

D. Fuster, R. Muga, C. Llorente, 2023, Alcohol.

Five-Year Incidence of Hospital-Based Emergencies Related to Acute Recreational Intoxication in Minors.

E. Papaseit, L. García-Eroles, R. Muga, 2019, Alcoholism, clinical and experimental research.

Loss of naive T lymphocytes is associated with advanced liver fibrosis in alcohol use disorder.

E. Martínez-Cáceres, D. Fuster, R. Muga, 2020, Drug and alcohol dependence.

Sex-specific Associations of Alcohol Withdrawal in Patients Admitted for the Treatment of Alcohol Use Disorder.

G. Rubio, M. Torrens, F. Rodríguez de Fonseca, 2020, Journal of addiction medicine.

Substance use disorder: Epidemiology, medical consequences and treatment.

D. Fuster, R. Muga, P. Zuluaga, 2024, Medicina clinica.

Cytotoxic NK cells phenotype and activated lymphocytes are the main characteristics of patients with alcohol-associated liver disease

E. Martínez-Cáceres, D. Fuster, R. Muga, 2023, Clinical and Experimental Medicine.

Vitamin D Deficiency Is Associated with Advanced Liver Fibrosis and Impaired Fasting Glucose in Alcohol Use Disorder

D. Fuster, Anna Hernández-Rubio, C. Garcia-Martín, 2024, Nutrients.

Associations of hypomagnesemia in patients seeking a first treatment of alcohol use disorder.

L. Miquel, M. Farré, G. Rubio, 2023, Drug and alcohol dependence.